AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitaprize M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Mnicro Labs Pvt. Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaprize M 500 Tablet

Diabex Duo 500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo 500mg may be used independently or alongside other antidiabetic therapies. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is personalized based on your health, glucose levels, and other medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Maintaining your prescribed diet and exercise regimen is crucial for effective diabetes management; lifestyle choices significantly impact glycemic control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when used with insulin or sulfonylureas; learn to recognize and manage this complication. This medication isn't suitable for all patients. Inform your physician of any prior kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or lactating women require medical consultation before use. Other medications may interact with Diabex Duo 500mg; disclose all current medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Uses of Sitaprize M 500 Tablet

Managing type 2 diabetes

Major Benefits of Sitaprize M 500 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitaprize M 500 Tablet with a meal.

Common Side effects of Sitaprize M 500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaprize M 500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaprize M 500 Tablet with a meal.

How Sitaprize M 500 Tablet works:

Sitagliptin and metformin, the components of Sitaprize M 500 Tablet, work synergistically to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and heightens insulin sensitivity. This combined action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitaprize M 500 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitaprize M 500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sitaprize M 500 Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitaprize M 500 Tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitaprize M 500 Tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disease should likely not take Sitaprize M 500 Tablets; use is inadvisable. Medical advice is recommended.

What if you forget to take Sitaprize M 500 Tablet :

Should you forget to take a Sitaprize M 500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaprize M 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sitaprize M 500 Tablet

Sitaprize M 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Prolonged Sitaprize M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitaprize M 500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitaprize M 500 Tablet components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitaprize M 500 Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitagliptin/Metformin (Sitaprize M 500 Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those consuming large quantities of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaprize M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaprize M 500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaprize M 500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaprize M 500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitaprize M 500 Tablet) can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitaprize M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaprize M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaprize M 500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaprize M 500 Tablet components or excipients, or those suffering from severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitaprize M 500 Tablet and alcohol is unsafe due to an increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitaprize M 500 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaprize M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), urinary problems, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaprize M 500 Tablet
151
MRP 175
13% off